Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
60.42(c) 60.9(c) 61.44(c) 61.8(c) 61.26(c) Last
461 759 335 782 369 025 319 700 440 759 Volume
-1.40% +0.79% +0.89% +0.59% -0.87% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 21 090 M - -
Net income 2021 1 271 M - -
Net Debt 2021 13 395 M - -
P/E ratio 2021 16,2x
Yield 2021 1,96%
Sales 2022 22 163 M - -
Net income 2022 1 465 M - -
Net Debt 2022 12 920 M - -
P/E ratio 2022 13,9x
Yield 2022 2,14%
Capitalization 20 904 M 20 877 M -
EV / Sales 2021 1,63x
EV / Sales 2022 1,53x
Nbr of Employees 123 538
Free-Float 67,8%
More Financials
Company
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines,... 
More about the company
Ratings of Fresenius Medical Care AG & Co. KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan maintains a Sell rating
MD
10/21FMC FRESENIUS MEDICAL CARE AG & CO K : Barclays reaffirms its Neutral rating
MD
10/18European ADRs Move Lower in Monday Trading
MT
10/07FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies maintains a Sell rating
MD
10/07FMC FRESENIUS MEDICAL CARE AG & CO K : NorldLB reiterates its Buy rating
MD
10/07Fresenius Medical Care AG & Co. KGaA acquired Sugerencias Medicas S.A.
CI
10/05FRESENIUS MEDICAL CARE : donates 250,000 euros to UNICEF - battle against COVID-19 pandemi..
AQ
10/05FMC FRESENIUS MEDICAL CARE AG & CO K : Barclays reiterates its Neutral rating
MD
09/30FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the German Securiti..
DJ
09/30FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 41 of the WpHG [the Ge..
DJ
09/30FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 41 of the WpHG [the Ge..
EQ
09/30FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan gives a Sell rating
MD
09/27VIFOR PHARMA : Gets Japanese Marketing Authorization For Avacopan in Autoimmune Kidney Dis..
MT
09/23European ADRs Move Sharply Higher in Thursday Trading
MT
09/23FRESENIUS MEDICAL CARE PUBLISHES 202 : Embracing the Complexity of Global Healthcare
PU
More news
News in other languages on FRESENIUS MEDICAL CARE AG & CO. KGAA
10/22WOCHENVORSCHAU/1. bis 7. November (44. KW)
10/18Les ADR européens en baisse lundi
10/05DGAP-NEWS : Novartis Pharma GmbH: Digitaler Gesundheitspreis für innovative E-Health-Proje..
10/04FRESENIUS MEDICAL CARE : spendet 250.000 Euro an UNICEF – 25-jähriges Unternehmensju..
09/30FRESENIUS SE & CO. KGAA : Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG m..
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | FME | DE0005785802 | MarketScreener
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 71,35 $
Average target price 80,88 $
Spread / Average Target 13,4%
EPS Revisions
Managers and Directors
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer
Sector and Competitors